Daniel C. Martin, Chief Commercial Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 35,602 shares at $12.57 ($448K) on 2023-11-30, disclosed to the SEC on 2023-12-01.
Open-market sale of $448k DCPH by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.57 | 17,801 | $224K | 50.0% |
| 2 | $12.57 | 17,801 | $224K | 50.0% |
| Total | $12.57 avg | 35,602 | $448K | 100% |
| Filing → |
| DCPH | SELL | 2023-12-14 | $27K | — | Filing → |
| DCPH | SELL | 2023-10-31 | $17K | — | Filing → |
| DCPH | SELL | 2023-06-21 | $18K | — | Filing → |